Symbol
RPTX
Investment type
Equity / Common shares, no par value
Latest Disclosed Shares Owned
1,941,242 shares
Security Ownership %
4.6%

ANSBERT GADICKE ownership in Repare Therapeutics Inc. Common shares, no par value (RPTX)

31 Jan 2025 - ANSBERT GADICKE has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,941,242 shares of Repare Therapeutics Inc. Common shares, no par value (RPTX). This represents 4.6% ownership of the company. In their previous filing dated 15 Jan 2025, MPM BioVentures 2014, L.P. had reported owning 2,149,415 shares, indicating a decrease of +9.7%. .